Strategies for non-viral vectors targeting organs beyond the liver

J Kim, Y Eygeris, RC Ryals, A Jozić, G Sahay - Nature nanotechnology, 2024 - nature.com
In recent years, nanoparticles have evolved to a clinical modality to deliver diverse nucleic
acids. Rising interest in nanomedicines comes from proven safety and efficacy profiles …

Nanomedomics

G Liang, W Cao, D Tang, H Zhang, Y Yu, J Ding… - ACS …, 2024 - ACS Publications
Nanomaterials have attractive physicochemical properties. A variety of nanomaterials such
as inorganic, lipid, polymers, and protein nanoparticles have been widely developed for …

Multimodal nanoparticle‐containing modified suberoylanilide hydroxamic acid polymer conjugates to mitigate immune dysfunction in severe inflammation

N Truong, AL Cottingham, S Dharmaraj… - Bioengineering & …, 2024 - Wiley Online Library
Excessive immune activation and immunosuppression are opposing factors that contribute
to the dysregulated innate and adaptive immune responses seen in severe inflammation …